Chugai Pharmaceutical's revenue 2013-2022

Published by
Catharina Klein,
Jun 6, 2024
In the fiscal year 2022, the revenue of the Japanese company Chugai Pharmaceutical Co., Ltd. amounted to approximately 1.17 trillion Japanese yen, its highest revenue of the past decade. Due to exports of in-house developed products, the company's revenue is expected to continue its ongoing growth.
Since 2002, Chugai Pharmaceutical is a subsidiary of the Swiss pharmaceutical company F. Hoffmann-La Roche Ltd.

Annual revenue of Chugai Pharmaceutical Co., Ltd. from 2013 to 2022 (in billion Japanese yen)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

May 2023

Region

Japan

Survey time period

2013 to 2022

Supplementary notes

100 Japanese yen equal 0.69 U.S. dollars or 0.64 euros as of July 2023.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Italy "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Italy

Industry overview

8

Key players

8

International trade

6

Research and development

4

Outlook

7

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPfizerNovartis
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.